Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Synthesis and biological activity of a novel series of indole-derived PPARgamma agonistsB R Henke, K K Adkison, S G Blanchard, et al.
Cancer Research|December 20, 1999
Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancerS A Fuqua, R Schiff, I Parra, et al.
The Journal of Biological Chemistry|May 25, 2001
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonistsJ M Way, C Z Görgün, Q Tong, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2001
Identification of a series of PPAR gamma/delta dual agonists via solid-phase parallel synthesisK G Liu, M H Lambert, L M Leesnitzer, et al.
Biochemical and Biophysical Research Communications|June 24, 1998
Cloning and characterization of human estrogen receptor beta isoformsJ T Moore, D D McKee, K Slentz-Kesler, et al.
Molecular Endocrinology (Baltimore, Md.)|October 24, 2000
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gammaY Wang, W W Porter, N Suh, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weightK G Liu, M H Lambert, A H Ayscue, et al.
The Journal of Biological Chemistry|May 29, 2000
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposityM Guerre-Millo, P Gervois, E Raspé, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaS A Kliewer, S S Sundseth, S A Jones, et al.
Endocrinology|September 1, 1997
Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in boneT M Willson, J D Norris, B L Wagner, et al.
Pageof 7